Erythropoietin (EPO) Peptide
EPO
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all EPO products
- EPO (Erythropoietin (EPO))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KEAISPPDAA SAAPLRTITA DTFRKLFRVY SNFLRGKLKL YTGEACRTGD
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of EPO antibody,
Alternative Names: EPO control peptide, EPO antibody Blocking Peptide, Anti-EPO Blocking Peptide, Erythropoietin Blocking Peptide, EP Blocking Peptide, MGC138142 Blocking Peptide, Erythropoietin-Alpha Blocking Peptide, EPO-a Blocking Peptide, EPO-alpha Blocking Peptide, Epoetin Blocking Peptide, EP Blocking Peptide - Purification
- Prepared from rabbit serum by affinity purification via sequential chromatography on phospho- and dephospho-peptide affinity columns.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- EPO (Erythropoietin (EPO))
- Target Type
- Hormone
- Background
- This gene is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.
- Molecular Weight
- 18 kDa
-
You are here:
